Our events programme, whether face to face, virtual or hybrid, plays a significant part in facilitating connections and advancing innovations.
The Biomedical Research Exchange for Academia, Clinicians and Health Tech (BREACH) and the Medicine Discovery Catapult are bring together the second Biomarker Matchmaking event in the series.
The event is brought to you by MedCity and the Northern Health Science Alliance (NHSA) to demonstrate the growth and excellence across the UK Life Sciences sector and what more could be achieved by bringing together investors and innovators in this area.
8 Feb 2023 Advances in Clinical Trials- Faster and Better. Equality, Diversity & Inclusion in Clinical Trials Roundtable
MedCity and NIHR are organising a Roundtable focusing on EDI in Clinical Trials; as part of the Faster and Better series
Collaborate to Innovate Networking: Featuring Advanced Therapies, Stroke Therapies and London Diagnostics Cohorts
22 Nov 2022 UKAT: Introduction to the Innovation Hubs for Gene Therapies, in partnership with MRC and LifeArc
This event will introduce the Advanced Therapies Network to the Innovation Hubs for Gene Therapies.
10 Oct 2022 UKAT: Commercialisation of academic research in cell and gene therapies- successes and investment opportunities from the UKAT
Commercialisation of academic research in cell and gene therapies panel discussion satellite event the the ESGCT / BSGCT Annual Congress
MedCity and NIHR are organising their 2nd event in the ‘faster and better’ series to promote collaboration between companies and NHS Foundation Trusts to demonstrate ‘the art of the possible’ and to promote shared learning between those sites that are already engaged in novel ways to conduct trials.
UKAT is an initiative to join up centers of excellence across the UK, to catalyse collaboration and innovation in Advanced Therapies.
Collaborate to Innovate London Diagnostics (C2N) is the latest MedCity programme funded by LEAP, which enables funded collaborative R&D projects/commercial mentorship opportunities for selected London based Diagnostic SMEs that help validate and bring their products/technologies to market.
A showcase of investment potential, innovation pathways and the power of cross-regional collaboration in Health and life Sciences.